Earnings Feed
Start Free
Home/Filings/4/0001185185-17-000411
4//SEC Filing

U.S. Stem Cell, Inc. 4

Accession 0001185185-17-000411

$USRMCIK 0001388319operating
View on SEC.govCompany Profile

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:30 PM ET

Size

6.0 KB

Accession

0001185185-17-000411

Insider Transaction Report

Form 4
Period: 2017-02-06
U.S. Stem Cell, Inc.BHRT.OB
TOMAS MIKE
DirectorCEO & President
Transactions
  • Award

    Stock Option (right to buy)

    2017-02-06+10,000,000→ 21,841,284 total
    Exercise: $0.00Exp: 2027-02-06→ Common Stock (10,000,000 underlying)
Holdings

  • Common Stock

    9,793
Footnotes (1)
  • [F1]2,500,000 vest on 02/06/2018, 2,500,000 vest on 02/06/2019, 2,500,000 vest on 02/06/2020, and 2,500,000 vest on 02/06/2021.

Documents

1 file

Issuer

U.S. Stem Cell, Inc.

CIK 0001388319

→
Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001388319

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:30 PM ET
Size
6.0 KB
View on SEC.gov